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We thank El Emam and colleagues for describing key concepts and principles for anonymising health data
(particularly individual patient data) in such a way that retains their utility for health research.1 Beneficially, the
authors describe and show how anonymisation is not a Sisyphean task (or a failure2) for much health data,
and that robust standards and guidance exist that can help data custodians sufficiently protect data while
promoting the use of data for various research purposes. We agree wholeheartedly that anonymisation can,
depending on context, serve to meet both of these ends. However, we wish to nuance a couple of the points
El Emam and colleagues make in the context of European data protection law.
First, we desire to expand on the statement (apparently stemming from the recent, admittedly ambiguous,
Article 29 Data Protection Working Party report on anonymisation techniques3 as well as earlier
commentary4) that, ‘In most jurisdictions, including the European Union, anonymisation is considered a
permitted use. This means that it is not necessary to obtain patient consent to anonymise the data.’1
Anonymisation, which we take to signify a process performed on personal data (thus making the personal
data no longer identifiable), is categorically distinct from anonymous data, which we take to signify a status of
data, namely data that never were identifiable. This is a crucial distinction because it means that as per
Recital 26 of the EU Data Protection Directive, the processing of personal data for the purposes of achieving
anonymisation (i.e. the rendering of personal data to an anonymised state) remains subject to data protection
laws because prior to the completion of this process, the data are still personal. In data protection terms, it is
‘further processing’.
Further consequences are that there must be a legitimate basis for anonymisation of personal data on any of
the grounds mentioned in Article 8(2) of the Data Protection Directive (including the data controller’s legitimate
interests). Additionally, the data quality principles of Article 6 of the Directive must be satisfied, as must
Articles 10 and 11, which require data custodians to inform patients (subject to exemption) of the purposes of
anonymisation and its effects, and their right to object to processing (Article 14). Even if anonymisation is
‘compatible with the original purposes of the processing’ as the 2014 Working Party report opines,3 this
Consent and anonymisation: beware binary constructions | The BMJ http://www.bmj.com/content/350/bmj.h1139/rr
1 of 3 20/07/2015 15:18
satisfies only the principle of data quality (Article 6), not a basis for making further processing of patient data
lawful (Article 8), nor the obligations under Articles 10, 11 and 14. In other words, satisfying Article 6 does not
absolve a data custodian of his other data protection obligations. European data protection laws offer an array
of legitimate bases for processing data – of which consent is only one – but the point remains: a legitimate
basis must be afforded. Anonymisation of individual patient data in Europe cannot proceed absent
authorization under the law. Thus, while it is arguably correct that consent may not be needed to anonymise
individual patient data (though even this is debatable under European Court of Human Rights jurisprudence,
which suggests any further processing of health data requires consent5), some legitimate basis under the law
is needed. As Deryck Beyleveld and David Townend note, ‘the only times that data rendered non-personal
can be said to be beyond the scope of the principles of protection is where the data no longer has a history
that can link it to an identifiable data controller who obtained the personal source data from the data subject or
where it is known that the source data was given for unlimited purposes.’6
This brings us to our second point. The two legal mechanisms El Emam and colleagues highlight that would
permit data custodians to share patient data for secondary purposes (absent an exemption in the law),
namely consent and anonymisation, should not be treated as a legal binary nor as a necessary and sufficient
condition for ethical health research. Individual patient data that been anonymised does not absolve data
custodians (and data users generally) from their legal obligations for all time coming, and equally it does not
absolve them from ethical obligations. As anonymisation is a process and not a status, it impels researchers
to consider how uses of these data may impact on the interests or sensibilities of patients and their connected
others (e.g. family and community members) across time. Law does not provide guidance here; the law
permits certain uses of anonymised data, but it does sufficiently guide us how they should be used. As the
recent Nuffield Council on Bioethics report aptly remarks, ‘[c]ompliance with the law cannot guarantee that a
use of data is morally acceptable. Faced with contemporary data science and the richness of the data
environment, protection of privacy cannot reliably be secured merely by anonymisation of data or by using
data in accordance with the consent from “data subjects”. Effective governance of the use of data is
indispensable.’7 Thus, researchers must always ask what privacy norms are engaged by use of data,
including whether anonymisation is appropriate, whether ostensibly anonymised data can re-become
identifiable, and who will have access to the data and for what purposes. Deryck Beyleveld notes that as
privacy is a subjective notion that broadly defined can include a right to know for oneself the personal
implications of research, anonymisation can violate privacy rather than protect it.8 These observations require
us to look beyond the ‘consent or anonymise’ paradigm, to understand that additional controls on data, such
as data access and follow-on use restrictions, implicate both administrative and technical aspects and are
vital for effective information governance.9
El Emam and colleagues have made a fine contribution to the literature about the benefits of anonymisation
and sharing of individual patient data. But it behoves us to be cognizant that the binary construction of
‘consent or anonymise’ is more rhetoric than reality, and that our ethical and legal obligations owed to patients
must always reach beyond the narrow confines of a consent form or a technical process. These are enduring
obligations that persist as long as the data have value, which is to say, until they are extinguished.
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